Herein, we present a detailed case of an EGFR-mutant LCNEC that underwent sequential morphologic evolution into SCLC and subsequently displayed characteristics consistent with adenocarcinoma, underscoring the dynamic nature of therapeutic resistance and the value of adaptive treatment strategies (6). The gene discussed is EGFR; the disease is small cell lung carcinoma.